The receptor, called GPR133, appears to help bones stay strong by supporting the cells that build bone and restraining the ...
Despite the risk of subsequent fractures in patients with osteoporosis, only approximately 20% of patients nationally receive the appropriate evaluation and treatment following a fragility fracture. A ...
Efforts to identify older men at risk for osteoporosis and treat those who are eligible received a boost from results reported from a Veterans Affairs (VA) study that showed a significant increase in ...
Axial involvement and osteoporosis were significantly associated with treatment switching among patients with pediatric CNO.
ANSWER: Denosumab (Prolia) is a treatment for osteoporosis that is normally given as an injection every six months. Among its ...
Osteopenia causes reduced bone density without symptoms, driven by aging, hormones, and lifestyle factors. Early detection ...
HOUSTON, March 02, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on ...
After my mom’s osteoporosis diagnosis scared the hell out of me, I went down a research rabbit hole that honestly kept me up at night for weeks. Most people are still using bone health strategies from ...
Eating foods rich in protein, calcium, and vitamin D can help prevent osteoporosis. Regular exercise, including weight-bearing and balance exercises, lowers the risk of fractures. Avoiding smoking and ...
Denosumab (Prolia) is a leading treatment for osteoporosis, but the rapid bone loss that can occur after discontinuing the RANK ligand inhibitor can be challenging to navigate. "I don't think we have ...
Research presented at WCO suggests men are referred too late for osteoporosis screening, with significantly lower survival after first DXA scans.